RHOA and Alzheimer disease: Dysregulation of RhoA is thought to contribute to AD pathogenesis by increasing neurite retraction, Aβ aggregation, tau hyperphosphorylation, neuroinflammation, and synaptic damage (Cai et al., 2021; Schmidt et al., 2022).